Summaries of scientific recommendations on classification of advanced-therapy medicinal products
The European Medicines Agency's Committee for Advanced Therapies delivers scientific recommendations on whether a medicine can be classified as an advanced-therapy medicinal product (ATMP). The Agency publishes the outcomes of these assessments in the format of summary reports.
Click on this link for more information.
